fbpx

Sharon Osbourne Says She Took Ozempic Weight Loss Too Far

Sharon Osbourne Says She Took Ozempic Weight Loss Too Far featured image
Getty Images / Katja Ogrin / Stringer

In a candid revelation on Piers Morgan Uncensored, Sharon Osbourne recently opened up about her Ozempic weight loss journey with the diabetes drug semaglutide that has gained popularity as a weight-loss aid. During an appearance with her husband Ozzy and children Jack and Kelly, she shared that she may have taken her weight loss too far.

“I didn’t want to go this thin. It just happened,” the 70-year-old host of The Talk UK confessed. “You can’t stay on it forever. I’ve lost 42 pounds now, and it’s just enough.”

Kelly Osbourne also recently admitted that she too might have gone a little too far. The reality star said post-pregnancy weight loss pressures led to her getting too thing as well.

Sharon said her Ozempic weight loss journey also came with nausea. “You don’t throw up physically, but you have that feeling,” she explained. “I was about two to three weeks where I felt nauseous the whole time. You get very thirsty, and you don’t eat.”

She also expressed concern about the drug’s potential misuse by younger individuals, she stated, “That’s why I say you have to keep this stuff away from younger people. They will go berserk on it, and it’s not right.”

Sharon also addressed her plastic surgery procedures, including a full facelift. She candidly shared her post-surgery experiences and joked, “I looked like a f—ing Cyclops. I’m, like, ‘All I need is a hunchback.’“

Despite her ongoing transformation, Sharon hinted that she might not remain at her current size for long, saying, “I’ll probably put it all on again soon. I’ve done it my whole life.”

Related Posts

Find a Doctor

Find a NewBeauty "Top Beauty Doctor" Near you

Give the Gift of Luxury

NewBeauty uses cookies for various reasons, including to analyze and improve its content and advertising. Please review our Privacy Policy and Terms of Use for more about how we use this data. By continuing to use this site, you agree to these policies.